Overview

Percutaneous Ketamine Versus Lidocaine for Mid-Sternotomy

Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Since midsternotomy is painful postoepratively, and since ketamine has been shown to be optimal postoeprative analgessic adjuvant, the investigators wish to assess its percutaneous preemptive effect, comparing it to lidocaine effect.
Phase:
Phase 4
Details
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Treatments:
Ketamine
Lidocaine